VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
134 hedge funds and large institutions have $384M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 43 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
18% less call options, than puts
Call options by funds: $5.11M | Put options by funds: $6.21M
Holders
134
Holding in Top 10
1
Calls
$5.11M
Puts
$6.21M
Top Buyers
| 1 | +$6.25M | |
| 2 | +$1.49M | |
| 3 | +$1.36M | |
| 4 |
Millennium Management
New York
|
+$1.32M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$592K |
Top Sellers
| 1 | -$20.2M | |
| 2 | -$3.27M | |
| 3 | -$1.73M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.62M |
| 5 |
Citigroup
New York
|
-$1.26M |